South Korea

DeepQure Initiates Early Feasibility Study for Groundbreaking HyperQure™ System Following FDA Approval

DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), announce...

 June 11, 2024 | News

Merck Life Science Breaks Ground on €300 Million Bioprocessing Production Center in Daejeon

Merck Life Science proudly announces the groundbreaking of its new, state-of-the-art Bioprocessing Production Center in Daejeon, representing our largest i...

 May 30, 2024 | News

SK Telecom Launches AI-Based Veterinary X-Ray Service 'X Caliber' in Australia

In collaboration with ATX Medical Solutions, SKT launches X Caliber in Australia, which has one of the highest rates of pet ownership in the world ...

 May 29, 2024 | News

HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology

Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...

 May 29, 2024 | News

Vatech Partners with Tygerberg Hospital to Enhance Dental Healthcare in South Africa

Vatech, a global leader in the dental imaging market, is launching a project to improve dental healthcare in South Africa. Vatech announced that it ha...

 May 24, 2024 | News

GCCL Introduces First ddPCR Device in South Korea for Enhanced Clinical Trial Sample Analysis

Introduced the first ddPCR device in Korea to provide high-quality clinical trial sample analysis services by increasing test accuracy Differentiate glo...

 May 23, 2024 | News

Lunit Completes Acquisition of Volpara Health Technologies, Enhancing AI-Driven Cancer Diagnostics

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proudly announces the successful completion of i...

 May 23, 2024 | News

GC Biopharma and Novel Pharma Receive FDA IND Approval for MPS IIIA Treatment 'GC1130A'

GC Biopharma and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval.   With this appr...

 May 21, 2024 | News

SN Bioscience’s SNB-101 Receives FDA Fast Track Designation for Breakthrough Small Cell Lung Cancer Treatment

SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (...

 May 13, 2024 | News

Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea

Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open ...

 May 08, 2024 | News

Sciwind Biosciences and HK inno.N Forge Partnership to Bring New Diabetes Treatment to South Korea

Sciwind Biosciences Co., Ltd., a clinical stage biopharmaceutical company focused on developing treatments for metabolic disease, and HK inno.N Corporation...

 May 07, 2024 | News

HanAll Launches Phase III VELOS-4 Trial for Tanfanercept in Dry Eye Treatment

HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Pha...

 May 06, 2024 | News

AriBio Secures EMA Approval for Pivotal POLARIS-AD Alzheimer's Trial, Aligning with FDA and MHRA

AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzh...

 April 30, 2024 | News

Onconic Therapeutics Gains South Korean Approval for Innovative GERD Treatment JAQBO

Onconic Therapeutics, a leading biotechnology company in Korea,  announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQB...

 April 26, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in